Antibodies
15 June 2007
Genmab initiates ofatumumab frontline NHL study12 June 2007
Viventia Biotech initiates patient treatment for Phase I trial of VB6-845 anti-cancer antibody8 June 2007
Remicade(R) Receives EU Approval as First and Only Biologic Treatment for Pediatric Crohn’s Disease8 June 2007
Abbott’s HUMIRA(R) (Adalimumab) Approved in the European Union for the Treatment of Crohn’s Disease6 June 2007
Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab6 June 2007
Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCONews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports